ala pro 7 amino 4 methylcoumarin ap amc (Valiant Co Ltd)
91
Structured Review
Valiant Co Ltd
ala pro 7 amino 4 methylcoumarin ap amc
Ala Pro 7 Amino 4 Methylcoumarin Ap Amc, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 91/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/03amc04210/Ala-Pro-7-amino-4-methylcoumar/pmc10042216-243-0-3
Average 91 stars, based on 3 article reviews
Ala Pro 7 Amino 4 Methylcoumarin Ap Amc, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 91/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/03amc04210/Ala-Pro-7-amino-4-methylcoumar/pmc10042216-243-0-3
Average 91 stars, based on 3 article reviews
ala pro 7 amino 4 methylcoumarin ap amc - by Bioz Stars,
2026-09
91/100 stars
Images
Related Articles
other:Article Title: Protein folding stress potentiates NLRP1 and CARD8 inflammasome activation Article Snippet: Article Title: The NLRP1 and CARD8 inflammasomes detect reductive stress Article Snippet: Inhibition:Article Title: Chronic administration of DSP-7238, a novel, potent, specific and substrate-selective DPP IV inhibitor, improves glycaemic control and beta-cell damage in diabetic mice. Article Snippet: Chronic administration of DSP-7238, a novel, potent, specific and substrate-selective DPP IV inhibitor, improves glycaemic control and β-cell damage in diabetic mice Y. Furuta1, M. Horiguchi1, E. Sugaru1, M. Ono-Kishino1, M. Otani1, M. Sakai1, Y. Masui1, A. Tsuchida1, Y. Sato2, K. Takubo2, H. Hochigai3, H. Kimura3, H. Nakahira3, T. Nakagawa1 & M. Taiji1 1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co. Ltd., Osaka, Japan 2Genomic Science Laboratories, Dainippon Sumitomo Pharma Co. Ltd., Osaka, Japan 3Chemistry Research Laboratories, Dainippon Sumitomo Pharma Co. Ltd., Osaka, Japan Activity Assay:Article Title: Chronic administration of DSP-7238, a novel, potent, specific and substrate-selective DPP IV inhibitor, improves glycaemic control and beta-cell damage in diabetic mice. Article Snippet: Chronic administration of DSP-7238, a novel, potent, specific and substrate-selective DPP IV inhibitor, improves glycaemic control and β-cell damage in diabetic mice Y. Furuta1, M. Horiguchi1, E. Sugaru1, M. Ono-Kishino1, M. Otani1, M. Sakai1, Y. Masui1, A. Tsuchida1, Y. Sato2, K. Takubo2, H. Hochigai3, H. Kimura3, H. Nakahira3, T. Nakagawa1 & M. Taiji1 1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co. Ltd., Osaka, Japan 2Genomic Science Laboratories, Dainippon Sumitomo Pharma Co. Ltd., Osaka, Japan 3Chemistry Research Laboratories, Dainippon Sumitomo Pharma Co. Ltd., Osaka, Japan |
